Document:

Office Services Agreement

 Exhibit 10.7 
 OFFICE SERVICES AGREEMENT 
  

			
	Date of Agreement: December 24, 2010	  	Agreement No. 079-1436-11
		
	 Provider (also referred to in this Agreement as “We”, “Us” or

“Our”):
 Chartwell Consulting
Group, Inc.
 t/a Symphony Suites
	  	 Client (also referred to in this Agreement as “You” or “Your”):

Durata Therapeutics, Inc. 
 89
Headquarters Plaza
 North Tower, 14th Floor

Morristown, NJ 07960

 This writing sets forth Your Agreement with Us to provide You with designated office access and shared use with Our other
Clients of Our facilities, services and common areas. This Agreement consists of two (2) pages, together with the attached Schedule A (Financial Terms), the attached Schedule B (Local Rules and Regulations– which We may change from time to
time, after giving You written notice), and the attached Supplement(s). By signing this writing You and We agree to the terms and provisions contained in this writing and said attachments. You agree to inform Your employees, agents, representatives,
and contractors of these provisions. 

 

	1.	We agree to provide to You the office access and other monthly services as listed on Schedule A, and shared use of the facilities, services, equipment and common areas,
and You agree to use the same only for office purposes. You and We agree this Agreement will continue in effect for the time period set forth on Schedule A, and at Your option, may be extended for one additional year with an adjustment of 10% (ten
percent) above the Monthly Contract Charges (for Office Access and Furniture Rental only) shown in Schedule A by notifying Us in writing at least 60 days before the initial time period ends that You choose to exercise this option.

  

	2.	You acknowledge this Agreement is not a lease, does not give You any rights with Our Landlord, and does not give You any interest in Our offices, facilities, common
areas, Building, or the land on which they are located. Rather, this Agreement is a license arrangement which gives You use of these office access, facilities, services and common areas, subject to Our canceling this arrangement for cause. You agree
this Agreement will end when and if Our Landlord ends Our lease for Our offices and areas which is not scheduled to expire during the term. You acknowledge that You are not permitted to transfer Your rights under this Agreement to anyone, and that
any attempt by You, or anyone else, to transfer Your said rights, will not be effective to actually cause such a transfer to occur. You agree not to allow or permit anyone other than You, Your employees and business visitors to use this office
access, and shared use of Our facilities and areas. Notwithstanding the foregoing, You may, without Our consent, assign this Agreement to any person or entity that is Your parent company; a wholly owned subsidiary of Yours or of Your parent company;
the surviving entity of a merger You are involved in; or the buyer of all or substantially all of Your assets. 

  

	3.	In addition to Your office access, We provide You with the services identified in Schedule A and other services We offer. We are the only service providers authorized
to provide services available from Us in the offices and facilities. You agree that for the duration of this Agreement and for one year thereafter, neither You nor Your employees will solicit any of Our other Clients to provide or provide to them,
any of the services We are available or able to provide. 

  

	4.	You agree to fully and timely pay monthly in advance the Monthly Contract Charges set forth on Schedule A for the full time period of this Agreement and all renewals.
In addition, You agree to fully and promptly pay for any additional services You request of Us upon Our billing You. The fee schedule for these additional services is available upon request, and is updated by Us from time to time. You agree to pay
all charges authorized and/or requested by You, Your employees, agents, representatives and contractors. 

  

	5.	You agree to use Our offices, services and facilities in accordance with the provisions of this Agreement as a first -class office and only for the approved purpose You
have stated to Us. You agree to use these office access, services and facilities as required by laws, ordinances and regulations which apply to Your operations, including those which require You to have licenses and/or permits.

  

	6.	You must take good care of and not damage or make any changes to the office, facilities, furnishings and equipment We provide to You. At the end of this Agreement, You
must deliver the same to Us in good condition, normal wear and tear excepted. If any damage

	 	
to Our property should occur while in Your care, custody or control, You agree to pay reasonable repair/replacement costs; and You agree to notify Us immediately upon Your becoming aware of such
damage occurring. Only We are authorized to make repairs to Our property. 

  

	7.	We will endeavor to make available to You these services and facilities during the regular business hours described in Schedule B. However, upon 30 days prior notice,
We reserve the right to discontinue or modify the said services, facilities and charges (except office access) in response to changes from suppliers and adjust the charges accordingly. 

 

	8.	Due to the imperfect nature of verbal, written and electronic communications, We cannot guarantee the services or facilities We provide to You. We are not liable for
any loss or damage (direct or consequential) resulting from Our failure to properly provide a service, office access, or facility to You. We also are not liable, in any way for any failure until You have told Us about it and have given Us a
reasonable time to correct that failure. Our only obligation to You for any failure to render any service, or for error or omission by Us, or for any delay or interruption of service, is to make an adjustment to Your bill in an amount equal to the
charge for such service for the period during which the failure, delay or interruption continues. 

  

	9.	We and/or Our Landlord are not liable to You, or to anyone You invite or permit into Our offices or areas, for any injury (including death), loss or damage resulting
from the actions or omissions of Our employees, Clients, their guests, or anyone else, or resulting from any condition or failure of the offices access, facilities and/or areas provided by Us. You waive all claims You may come to have against Us
and/or Our Landlord for damage or loss to Your property arising from fire, theft, or other occurrences. However, You may exercise Your lawful rights to the extent there has occurred willful misconduct or gross negligence by Us or Our employees,
while under Our control, and such willful misconduct or gross negligence has caused You injury, loss or damages. 

  

	10.	You will have breached this Agreement if You do not fully and timely make the payments, perform the acts, and comply with the requirements, for which You are
responsible under this Agreement. 

  

	 	a.	If You breach this Agreement, We have the right to cease to provide to You the designated office access, as well as some or all of Our other services without Our first
obtaining a court order or other authorization. In the event of such a breach, We also have the right to terminate this Agreement early, and to exclude You, Your employees, agents, representatives, contractors, customers and visitors from Our
offices (including Your designated office access), facilities and areas. However, in the absence of an emergency, We agree not to take such action without first giving You written notice of Your breach (or breaches) and a 5 calendar day opportunity
to remedy all of Your breaches. Our failure to give You such written notice despite Your breach of this Agreement, does not mean We have waived Our right to do so in the future. 

 

	 	b.	Our early termination of this Agreement does not end Your obligations to Us. You will still be liable to Us for all unpaid and overdue fees for office access,
facilities 

 

  
  

							
	[] Symphony Suites. All Rights Reserved. CONFIDENTIAL Rev. 708	  	 	1	  	  	Initials: Client CF      Provider

	 	
and services, as well as for the Monthly Contract Charges listed in Schedule A, or those Monthly Contract Charges applicable at the time of termination, whichever is greater, for the remainder of
the current term of this Agreement. Upon Our early termination of this Agreement, the unbilled charges and/or remaining applicable Monthly Contract Charges will be due as a lump sum. 

 

	 	c.	If, while You are in breach of this Agreement You abandon, or are removed from Your office access and leave behind personal property of Yours, We may treat the same as
abandoned and dispose of the same as We see fit, at Your cost and expense. 

  

	11.	You agree to pay Us promptly upon demand, notwithstanding the expiration or Our early termination of this Agreement: 

 

	 	a.	The Monthly Contract Charges described in Par. 10b above; 

  

	 	b.	All costs, expenses, losses and damages, including legal costs and reasonable attorney’s fees, We suffer or incur because of Your failure to fully and timely
satisfy Your obligations under this Agreement, and/or in connection with Our efforts to enforce Your satisfaction and/or compliance with these obligations; and 

 

	 	c.	The reasonable cost of repair or replacement of Our offices, facilities, areas, furnishings, equipment and/or property because of their damage or destruction while in
your possession, or caused by Your use or misuse; and 

  

	 	d.	All charges associated with telephone fraud traceable to Your account. 

  

	12.	At the end of this Agreement, regardless of whether it has run its full time period or has been terminated early by Us, You agree as of the termination date:

  

	 	a.	To remove all of Your personal property and leave Our offices (including Your designated office areas), facilities and areas. We are not responsible for Your personal
property which remains after this termination date, and We may dispose of such personal property as We see fit, at Your cost and expense; and 

  

	 	b.	To leave Our offices (including Your designated office access), facilities and areas, in an acceptable condition normal wear and tear excepted; and

  

	 	c.	To return all keys and security cards; and 

  

	 	d.	To have completed Your notification to all of Your correspondents to stop using Our address and phone number. 

 

	13.	We, Our Landlord, and/or Landlord’s Lender have the right at any time to enter and/or inspect Your designated office to make repairs and/or to show the same to
prospective Clients. If this occurs during working hours, We shall use reasonable efforts to minimize disruption to Your business operations. 

  

	14.	All notices between You and Us must be in writing, and must be given as follows: 

 

	 	a.	For notices to You: Placed in the local mailbox, with a copy mailed by certified mail, return receipt requested, directed to Your address set forth at the beginning of
this Agreement with a follow-up email to Ben Pe [bpe@duratatherapeutics.com]. 

  

	 	b.	For notices to Us: Mailed by certified mail, return receipt requested, addressed to the Managing Officer, c/o SymphonySuites, 89 Headquarters Plaza, North Tower 14th
Floor, Morristown, NJ, 07960 

  

	15.	For the duration of this Agreement, You are authorized to use Our address as Your business address in the manner We prescribe using Your business name as it appears on
the first page of this Agreement or on the Client Application. We are not Your agent for the purpose of receiving legal papers on Your behalf. The phone number assigned to You is, and will always remain, Our property. It may not be used in any
published

	 	
directory without Our prior written consent which shall not be unreasonably withheld. If this Agreement ends by way of expiration, and without any uncured breach of this Agreement, You may
request mail or phone forwarding services following such expiration at Our stated rates and conditions. In the absence of mail forwarding instructions, We may, at Our option, and without notice, obligation or liability to You, return mail to sender
if returnable without charge to Us, or dispose of it if not returnable. After any expiration or termination of this Agreement and/or the services hereunder, if You should continue to use Our assigned mailing address or phone number in any current
directories; websites; letterheads; or in any place whereby it appears to business correspondents that You continue to maintain a presence at Our premises, You agree that You will pay Us a sum of 1.5 times Our usual fee for such usage for as long as
the usage continues. You further agree that We are not required to notify You in advance of imposing such fees. 

  

	16.	You agree to defend, reimburse and protect Us, Our officers, directors, employees, agents and affiliates (called “Our Group”) from and against all
obligations, liabilities, claims, damages, costs and fees (including reasonable attorney’s fees) which may be imposed upon, or asserted against, Our Group because of Your actions or omissions or those of Your employees, agents, representatives,
contractors, visitors or of those You permit to occupy or use Our offices, facilities and/or areas (called “Your Group”), or which arise out of Your failure to fully and timely pay, perform or comply with any provision or requirement
contained in this Agreement. 

  

	17.	You agree to pay for and maintain in force, for the duration of this Agreement, including all renewal time periods, a commercial general liability insurance policy
which insures You for the obligations You owe to Us under Paragraph 16 of this Agreement, and which also insures You, Us and Our Landlord Second ROC Jersey Associates as additional insured against claims for bodily injury (including death) and
property damage, occurring on, in, or about Our offices, areas and/or Building, with policy limits of at least $1 million combined single limit per occurrence. You agree to provide to Us a duly issued certificate of insurance memorializing these
insurance coverages, from an insurance company acceptable to Us, before You and We begin Our performance of this Agreement. 

  

	18.	If You become insolvent, transfer Your assets for the benefit of Your creditors, file, or there is filed against You, bankruptcy or insolvency lawsuits, We have the
right to immediately and without notice, terminate this Agreement early, and to exercise all of Our rights available under the law. 

  

	19.	The laws of New Jersey shall be used to resolve all disputes and to interpret this Agreement. The Superior Court of New Jersey is the only place in which You or We
shall present any and all disputes and/or claims either of Us may have concerning this Agreement and/or its performance. If a portion of this Agreement is determined to be invalid or unenforceable, that determination shall not affect the validity or
enforceability of the other provisions. 

  

	20.	This Agreement including its attached Schedules and Supplement(s), is the entire Agreement between You and Us; and it supersedes any and all previous Agreements,
arrangements and understandings We may have had (if any). This Agreement may not be changed or altered in any way except in writing signed by both You and We. This Agreement, and all changes to it, shall be effective only when signed by both You and
Our Managing Officer. 

 

  
 You and We sign this Agreement
below on behalf of ourselves, everyone who succeeds to Our interests, and everyone to whom You (with Our Consent) and/or We transfer rights under this Agreement. 
  

			
	Provider: Chartwell Consulting Group, Inc. t/a	  	Client: Durata Therapeutics, Inc., by:
	 SymphonySuites, by:
  

Signature:

        Date: 12/31/10
	  	Signature:

                         Date: 12/27/10
	Title: Managing Officer	  	Print Name & Title: Corey Fishman, Chief Operating Officer

  
  

							
		  	 	2	  	  	

 SCHEDULE A 
 FINANCIAL TERMS 
 Term of the Agreement: January 1, 2011 to December 31, 2012

  

											
	 Quantity
	  	 MONTHLY CONTRACT CHARGES
	  	Unit
Charge	 	 	Total Monthly	 
	 1
	  	Office Access for Office/Suite No(s). 1436; 1433; 1430; 1427; 1425; 1478; 1476; 1474 Including office cleaning, maintenance services, heating and air conditioning during normal
business hours	  	$	14,893	  	 	$	14,893	  
	 1
	  	Furniture Rental (see also Furniture Rental Supplement)	  	$	3,607	  	 	$	3,607	  
	 10
	  	Complete Multiline Telephone Equipment	  	$	40	* 	 	$	400	  
	 10
	  	Executive Telephone Upgrade w/display	  	$	20	  	 	$	200	  
		  	Dedicated Analog Modem Only Line	  	$	24	  	 			
	 2
	  	Dedicated Analog Fax & Modem Line	  	$	45	* 	 	$	90	  
		  	Local Area Network Nodes (with IP address)	  	$	20	  	 			
	 10
	  	High Speed T-1 Internet Service (includes LAN node for each)	  	$	30	* 	 	$	300	  
		  	Additional Voice Mailbox + Message Center	  	$	45	  	 			
		  	Attendant Answering	  	$	50	  	 			
		  	Attendant Screening (1st person)	  	$	120	  	 			
		  	Attendant Screening (additional person)	  	$	60	  	 			
	 10
	  	Indoor Parking (Morristown)	  	$	65	  	 	$	650	  
		  		  	$	0	  	 			
		  		  	$	0	  	 			
		  		  	$	0	  	 			
		  	Verizon Directory Listing	  	$	5	  	 			
		  	 TOTAL MONTHLY CONTRACT SERVICES/FACILITIES
	  				 	$	20,140	  
		  	 REFUNDABLE RETAINER
	  				 	$	40,280	  

  

	*	See current price schedule for one time setup charges 

 The above Services listing is not necessarily complete and may be amended from time to time to reflect changes in services and/or equipment. 

IMPORTANT: SEE TERMS ON BACK 

  
  

							
	[] Symphony Suites. All Rights Reserved. CONFIDENTIAL Rev. 708	  	 	3	  	  	Initials: Clien CF     Provider

 FINANCIAL TERMS (continued) 

 

	1.	You agree to pay Us in advance on the first day of each month for all Monthly Contract Charges, whether or not You have received an invoice from Us for the same. We
will bill variable charges for other services monthly and payment for such is due within 10 days of the invoice date. 

  

	2.	All of Your payments to Us must be made in United States currency or by checks drawn on United States banks. Payments made by credit card will be subject to an
additional fee of a least 3% or as imposed by the bank or issuing entity, whichever is higher. Returned checks will be subject to a fee of $25. 

  

	3.	You agree to pay a 5% late charge on any outstanding balance which We receive later than the 10th of the month in which it is due. Further if You fail to pay Us before
the 20th of the month in which a payment is due, You agree to pay interest charges at 1.25% per month until We receive payment. We are not limited to just requiring and receiving from You these interest and late payment charges, and may resort
to such remedies and actions as the law and/or this Agreement gives Us. 

  

	4.	You are responsible for payment of all applicable taxes on the services received under this Agreement. 

 

	5.	Should You give Us timely notice of Your intention to not renew this Agreement and fail to leave Our offices or remove Your property at the end of the term, the
services herein and this Agreement will automatically continue on a month-to -month basis with the following conditions: 

  

	 	a.	You will pay Office Access at a 100% premium above the charge in the last month of the regular term and 

 

	 	b.	Office Access will be paid in whole month increments only (even if occupancy only continues for a partial month), and 

 

	 	c.	In the last month of occupancy, You will provide Us with written notice in the first 15 days of that month of Your intention to end occupancy and the services hereunder
on the last day of that month. 

  

	6.	If You have signed a Furniture Rental Supplement of this Agreement, You agree to pay Us all monies You owe to Cadogan Resources, LLC. Your failure to fully and
timely do so shall be a breach of this Agreement, as well as a breach of the Furniture Rental Supplement. 

  

	7.	In the event an Amendment to this Agreement must be prepared for renewals, additions, extensions, changes, etc., the Amendment Processing Fee on the front of this
document shall apply. This Fee does not apply in the event of automatic renewal of a current Agreement. 

  

	8.	If You dispute any portion of Our charges, You agree to timely and fully pay to Us the portion of Our charges You do not dispute; and You further agree to advise Us in
writing, within 30 days after You receive Our bill, of the portion of said bill You dispute. If You do not advise Us in writing within this 30 day period that You dispute all or some of Our charges on said bill, You will have waived Your right to
dispute Our charges. 

  

	9.	We provide telephone service to You through Our carriers billed at or less than basic AT&T tariff rates depending upon usage level, and we do not charge for
incoming calls. We do not charge for Toll Free calls unless there is excessive trunk usage. We reserve the right to charge you any applicable provider fees and taxes plus: 

 

	 	a.	the standard FCC rate for each call if you use an alternate carrier and

	 	b.	a minimum usage of $30 per month per phone (which amount may be revised by Us with 30 days prior notice) to allow us to meet our contract usage levels and for incoming
trunks and 

  

	 	c.	charge a fee for additional broadband usage if any external VOIP calling services are used. 

 

	10.	Simultaneously with Your signing of this Agreement (of which this Schedule B is a part), You will pay a Refundable Retainer in the amount indicated on the reverse side
of this page. This Refundable Retainer may be applied by Us, at any time, at Our discretion, to the outstanding monies You owe to Us (whether for required payments, compensation for repairs or damages You have caused Us to make or suffer, or for
monies You owe to Cadogan Resources, LLC, under its Furniture Rental Supplement with You - if You have signed such a Supplement). We have the right to require that You replenish the Refundable Retainer by replacing dollar for dollar the funds We
apply from this Refundable Retainer. During or subsequent to the term of this Agreement, You cannot designate that the Retainer be applied toward any Monthly Contract or additional charges. At the expiration of the Agreement and when You have
satisfied all of Your obligations; vacated the premises; left the same in an acceptable condition normal wear and tear excepted; returned all keys and security cards; paid all charges; and removed Your property from Our premises, We will refund to
You the balance remaining of this Refundable Retainer within 45 to 60 days mailed to the person signing this Agreement at the Client Address above. 

  

	11.	In the event any of the walls in the offices occupied by You are marked or damaged in anyway, You agree to reimburse Us for a repainting charge at the time of moving
for all of the offices You occupy at a cost of $150.00 per room. 

  

	12.	Our staff and employees are an essential part of Our ability to deliver Our services. You acknowledge this, and agree that: 

 

	 	a.	You will not directly contract, or otherwise agree with, Our staff and employees for the performance of services; and will arrange for such performance only through Us;

  

	 	b.	You will not, during the duration of this Agreement, and for the one year period immediately following its expiration or early termination, directly or indirectly, hire
any person who has been an employee of Ours, or a member of Our staff at the location at which you have licensed offices hereunder at any time this Agreement was in effect, and 

 

	 	c.	If You violate the provisions of (b.) above, in addition to such other remedies as the law gives to Us, You agree to pay Us 30% of such person’s annual
compensation or $15,000.00, whichever is greater, for each of such persons You hire. You agree with Us that such a charge is a reasonable estimation of the loss We would suffer in such a situation, and that a more accurate calculation of Our loss
would be impracticable or extremely difficult to fix. 

 

  
  

							
	[] Symphony Suites. All Rights Reserved. CONFIDENTIAL Rev. 708	  	 	4	  	  	Initials: Client CF      Provider

 SCHEDULE B 
 LOCAL RULES AND REGULATIONS 

 

	1.	SymphonySuites is a community of professionals, and the office decorum should at all times reflect adherence by its members to the highest standards of conduct and
appearance for the benefit of all. You agree not to interfere with Our other Clients, or with the activities of Our employees, or those of Our Landlord, or its Tenants. 

 

	2.	Please respect others conducting business in the center by wearing appropriate business attire fitting a professional office environment during regular business hours.
As a minimum, specifically not permitted are shorts; jeans; athletic clothing; athletic footwear; denim clothing; shirts without collars (for men); hats; clothing with advertisements or logos; and other inappropriate articles of clothing.

  

	3.	Neither You nor anyone You invite into the premises can use Our facilities, premises, areas and/or property for immoral purposes or in such a manner as to violate
applicable laws, codes, regulations, and/or the conditions of Our insurance policies, or those of Our Landlord, or make these policies invalid or more expensive; nor in such a manner as is hazardous, unsafe, or which in Our opinion, or that of Our
Landlord, impairs the first class character of Our offices and/or Building. 

  

	4.	The following are prohibited on the premises at all times: 

  

	 	a.	Smoking 

  

	 	b.	Pets or other animals except bona fide seeing eye dogs 

  

	 	c.	Bicycles or other mobile transportation on the premises 

  

	 	d.	Hazardous materials or equipment-which would include halogen lamps, candles, solvents, paints, etc. 

 

	 	e.	Furnishings not specified by Us including desks, tables, chairs, bookcases, etc. 

 

	 	f.	Deleted 

  

	 	g.	Connection or installation of any telephone, broadband or communications equipment including cabling not provided by Us including wireless or other multipoint access
LAN’s 

  

	 	h.	Display of any signs, awnings, advertisements or projections which may be visible from any common area of the facilities or floor, or from the outside of the building

  

	 	i.	Installation or use of cooking equipment in Your office including hot plates; microwave ovens, etc. 

 

	 	j.	Storage or disposal of food in Your office 

  

	 	k.	Installation of any vending machines 

  

	 	l.	Use of the office for residential, dwelling or sleeping purposes 

  

	 	m.	Applying tape to any walls or furniture on the premises 

  

	 	n.	Changing of locks for doors and furnishings provided by Us 

  

	 	o.	Installation or use of any equipment which in Our judgement, or in the judgement of Our Landlord, cause any interference, impairment, discomfort, inconvenience or
annoyance to Us, Our Landlord or Our other Clients 

  

	5.	The following are prohibited without Our prior written consent which shall not be unreasonably withheld and may be subject to special instructions or fees:

  

	 	a.	refrigerators of all types and heavy objects such as safes, etc. 

  

	 	b.	installation of office equipment with power requirements beyond those of a desktop PC or laser printers 

 

	 	c.	use of electrical extension cables or power strips 

  

	 	d.	installation of wall hangings; whiteboards, lamps, etc. 

  

	 	e.	Storage of boxes or other objects in Your office which are visible from the hallways 

 

	 	f.	Plants resting on the furniture or floor 

  

	6.	You must ensure that noise emanating from Your office from radios; video equipment; cell phones, speaker phones, etc. cannot be heard beyond Your office.

  

	7.	All full-time Client staff working at SymphonySuites can be assigned pass cards and keys for 24 hour access to their offices. Do not transfer or duplicate these keys,
and they must be surrendered upon request or returned directly to Us at the end of Your employment or the Agreement term, whichever is sooner. If lost, there is a charge for replacement, as well as changing of the locks. After regular business hours
and all

	 	
day weekends, ensure that all doors leading to the outside or elevator corridor are securely locked at all times and do not admit any strangers, even if they claim to be visiting other clients.

  

	8.	The common areas including the hallways, ante-rooms, conference rooms, lunch room, reception area, etc. should be kept clean and uncluttered throughout the work day.
Therefore, after each use, leave all common areas clean and uncluttered, and carry all open beverages through the hallways using the provided lids. 

  

	9.	Please do not conduct meetings or business in the reception area, hallways or pantry. 

 

	10.	Janitorial services are available after 5:00 pm of each work day. For Clients leaving earlier, waste receptacles may be left in the Mens/Ladies Room for disposal.
Please do not leave receptacles or any objects for disposal in the hallways during working hours. 

  

	11.	Please do not use the offices for babysitting of children at any time. Older children using the facilities for work must adhere to the requirements of this Schedule
including dress standards. In addition, please inform Your visitors that children should not wait in the common areas at any time, or be heard anywhere on the floor during business hours. 

 

	12.	Regular business hours are 8:30 am to 5:00 pm Monday through Friday except Holidays. SymphonySuites staff Holidays are New Year’s Day, Memorial Day, Independence
Day, Labor Day, Thanksgiving Day, and Christmas Day. Please note that air conditioning may not be available outside of regular business hours and on building holidays based on the local building schedule. 

 

	13.	Do not remove furnishings or any other items from any other offices on the floor, even if they appear vacant. When using the wood furniture, please use desk mats,
coasters or felt bases to avoid causing scratches. All desk chairs must have a floor mat at all times. Repairs are costly and billable to You. 

  

	14.	You are responsible to make Your visitors aware of these rules. Violation may result, in some cases, in consequences which could include the issuance by Us of a notice
of default and/or the immediate removal from Our premises of the offending person. 

  

	15.	Our staff are required to maintain a helpful, but strictly professional relationship with Our Clients. Clients are prohibited from offering gratuities; presenting work
requests directly to Our staff outside of Our approved procedures; offering Our staff employment, developing personal or external business relationships with Our staff; or becoming involved in any relationships with Our staff which have the
potential for creating conflicts of interest, illegal conduct and/or the opportunity for allegations of sexual harassment. 

Other guidance is contained in the current Client Handbook, and is a part of these Rules and Regulations. These Rules and Regulations may be
supplemented, changed or deleted by SymphonySuites after written notice is given. 

 

  
  

							
	[] Symphony Suites. All Rights Reserved. CONFIDENTIAL Rev. 708	  	 	5	  	  	Initials: Client CF      Provider

 (Intentionally blank) 

  
  

							
		  	 	6	  	  	

 FURNITURE RENTAL SUPPLEMENT 
 Cadogan Resources, L.L.C. (referred to as “Cadogan” in this document) and Durata Therapeutics, Inc. (referred to as “You” or “Your” in this document), make this additional
Agreement (the “Supplement”) to the Office Services Agreement No. 079-1436-11 between You and Chartwell Consulting Group, Inc. t/a SymphonySuites (referred to as “SymphonySuites” in this document). Cadogan agrees to rent
to You and You agree to rent from Cadogan, on a week-to-week basis, the equipment and furniture listed on the Equipment/Furniture Addendum, on the reverse side of this page, for the length of term indicated and under the terms and conditions set
forth below. 

 

	1.	Your right to rent this equipment and furniture depends on Your Office Services Agreement with Symphony Suites, and if that Agreement ends, so will Your rights under
this Supplement. You may use this equipment and furniture only in connection with Your use of the designated office access, facilities and areas, provided to You by Symphony Suites, and only in accordance with the terms and provisions of the
Agreement with SymphonySuites. If You breach Your Agreement with SymphonySuites, Cadogan may, at its option, terminate this Supplement and Your rights in said equipment and furniture. Conversely, if You breach this Supplement, that breach will
also be a breach of Your Office Services Agreement with SymphonySuites. 

  

	2.	You agree to fully and timely pay in advance, the rental charges set forth on the Addendum, on the reverse side of this Supplement; and You also agree to fully and
timely satisfy the performances and requirements You have assumed in this Supplement with regard to said furniture and equipment. You agree to make all of Your payments to Cadogan, by making these payments to SymphonySuites – who serves as the
collection agent for Cadogan with regard to these payments. 

  

	3.	The equipment and furniture You are renting is, and shall always remain, the property of Cadogan. You are obligated to maintain said property in good physical
condition, and to protect Cadogan’s ownership rights in the furniture and equipment. Your obligations in this regard include the following: 

  

	 	a.	You must keep the equipment and furniture in good repair, condition and working order; 

 

	 	b.	You must not remove the equipment and furniture from the designated office area provided to You by SymphonySuites. 

 

	 	c.	You must use appropriate mats on all surfaces which are subject to direct contact or wear. You must return the equipment and furniture to Cadogan in good repair,
condition and working order. Conditions caused by ordinary wear and tear are acceptable, but not if this condition could have been prevented or lessened by Your using desk pads.

	 	d.	Only Cadogan is authorized to make repairs to the furniture. 

  

	 	e.	You will not use or offer Cadogan equipment or furniture as security for Your repayment of any debt or for the satisfaction of any of Your obligations.

  

	4.	You agree to protect and reimburse Cadogan from and with regard to all loss and/or damage Cadogan suffers because of Your failure to satisfy any of Your obligations
listed in this Supplement. Additionally, You are totally responsible for any and all loss or damage to the equipment and/or furniture regardless of how such loss or damage occurred normal wear and tear excepted. 

 

	5.	You agree to keep all rental equipment and furniture insured under an all risks/loss/damage insurance policy in an amount equal to what it would cost to fully replace
this equipment and furniture. You also agree to carry liability and property damage insurance covering this equipment and furniture and its use. The policies must defend, protect and reimburse Cadogan and Chartwell Consulting Group, Inc. t/a
SymphonySuites against with regard to, all claims, liabilities, damages and costs connected with, and resulting from, this equipment and/or furniture and/or its use. 

 

	6.	You acknowledge that You are not permitted to transfer Your rights under this Supplement to anyone, and that any attempt by You, or anyone else, to transfer Your said
rights, will not be effective to actually cause such a transfer to occur. 

  

	7.	Neither SymphonySuites nor Cadogan make any guaranty expressly or implied to You or anyone else concerning the fitness of said equipment and furniture for any
purpose, its salability, design, condition, performance capabilities or any other aspect of said equipment and furniture or concerning its material or workmanship.

 

  
 We sign this Supplement below on
behalf of ourselves, everyone who succeeds to Our interests, and everyone to whom We may transfer Our rights under this Supplement with Cadogan’s consent. 
  

											
	Cadogan Resources L.L.C.	 		 		 	Durata Therapeutics, Inc.
						
	Signature	 	

	 	 as Agent
	 		 	Signature	 	

  
  

							
		  	 	7	  	  	

 EQUIPMENT/FURNITURE ADDENDUM 

(To Be Submitted Later) 
 Rate
Basis: Two Year 
  

									
	Description	  	Room	  	Tag No.	  	Type	  	Cond
		  		  		  		  	

 Weekly Furniture Rental Charge $902 

Charges are billed monthly and the maximum charge in any full month will be based on four weeks billing. 

This Schedule may be amended to reflect requested changes in furnishings. However, if the Rate Basis is reduced for any furnishings, any increased
charges will be retroactive to the start of the rental period for the furnishings indicated. 
 Condition Codes 

N= New and unblemished. 
 E= Excellent-nearly new
with no visible surface scratches. 
 G= Good- Some surface wear may appear, but no surface scratches penetrate the polyurethane coating to the
wood. 
 F= Fair-Some minor scratches may appear on the work surface or edge only-side panels are free of all scratches. 

O= Other-see notes 

  
  

							
	[] Symphony Suites. All Rights Reserved. CONFIDENTIAL Rev. 708	  	 	8	  	  	Initials: Client              Provider
                        

 FURNITURE RENTAL SUPPLEMENT 
 Cadogan Resources, L.L.C. (referred to as “Cadogan” in this document) and Durata Therapeutics, Inc. (referred to as “You” or “Your” in this document), make this additional
Agreement (the “Supplement”) to the Office Services Agreement No. 079-1436-11 between You and Chartwell Consulting Group, Inc. t/a SymphonySuites (referred to as “SymphonySuites” in this document). Cadogan agrees to rent
to You and You agree to rent from Cadogan, on a week-to-week basis, the equipment and furniture listed on the Equipment/Furniture Addendum, on the reverse side of this page, for the length of term indicated and under the terms and conditions set
forth below. 

 

	1.	Your right to rent this equipment and furniture depends on Your Office Services Agreement with Symphony Suites, and if that Agreement ends, so will Your rights under
this Supplement. You may use this equipment and furniture only in connection with Your use of the designated office access, facilities and areas, provided to You by Symphony Suites, and only in accordance with the terms and provisions of the
Agreement with SymphonySuites. If You breach Your Agreement with SymphonySuites, Cadogan may, at its option, terminate this Supplement and Your rights in said equipment and furniture. Conversely, if You breach this Supplement, that breach will
also be a breach of Your Office Services Agreement with SymphonySuites. 

  

	2.	You agree to fully and timely pay in advance, the rental charges set forth on the Addendum, on the reverse side of this Supplement; and You also agree to fully and
timely satisfy the performances and requirements You have assumed in this Supplement with regard to said furniture and equipment. You agree to make all of Your payments to Cadogan, by making these payments to SymphonySuites – who serves as the
collection agent for Cadogan with regard to these payments. 

  

	3.	The equipment and furniture You are renting is, and shall always remain, the property of Cadogan. You are obligated to maintain said property in good physical
condition, and to protect Cadogan’s ownership rights in the furniture and equipment. Your obligations in this regard include the following: 

  

	 	a.	You must keep the equipment and furniture in good repair, condition and working order; 

 

	 	b.	You must not remove the equipment and furniture from the designated office area provided to You by SymphonySuites. 

 

	 	c.	You must use appropriate mats on all surfaces which are subject to direct contact or wear. You must return the equipment and furniture to Cadogan in good repair,
condition and working order. Conditions caused by ordinary wear and tear are acceptable, but not if this condition could have been prevented or lessened by Your using desk pads.

	 	d.	Only Cadogan is authorized to make repairs to the furniture. 

  

	 	e.	You will not use or offer Cadogan equipment or furniture as security for Your repayment of any debt or for the satisfaction of any of Your obligations.

  

	4.	You agree to protect and reimburse Cadogan from and with regard to all loss and/or damage Cadogan suffers because of Your failure to satisfy any of Your obligations
listed in this Supplement. Additionally, You are totally responsible for any and all loss or damage to the equipment and/or furniture regardless of how such loss or damage occurred normal wear and tear excepted. 

 

	5.	You agree to keep all rental equipment and furniture insured under an all risks/loss/damage insurance policy in an amount equal to what it would cost to fully replace
this equipment and furniture. You also agree to carry liability and property damage insurance covering this equipment and furniture and its use. The policies must defend, protect and reimburse Cadogan and Chartwell Consulting Group, Inc. t/a
SymphonySuites against with regard to, all claims, liabilities, damages and costs connected with, and resulting from, this equipment and/or furniture and/or its use. 

 

	6.	You acknowledge that You are not permitted to transfer Your rights under this Supplement to anyone, and that any attempt by You, or anyone else, to transfer Your said
rights, will not be effective to actually cause such a transfer to occur. 

  

	7.	Neither SymphonySuites nor Cadogan make any guaranty expressly or implied to You or anyone else concerning the fitness of said equipment and furniture for any
purpose, its salability, design, condition, performance capabilities or any other aspect of said equipment and furniture or concerning its material or workmanship.

 

  
 We sign this Supplement below on
behalf of ourselves, everyone who succeeds to Our interests, and everyone to whom We may transfer Our rights under this Supplement with Cadogan’s consent. 
  

											
	Cadogan Resources L.L.C.	 		 		 	Durata Therapeutics, Inc.
						
	Signature	 	

	 	 as Agent
	 		 	Signature	 	

  
  

							
		  	 	7	  	  	

 EQUIPMENT/FURNITURE ADDENDUM 
 Rate Basis: Two Year 
  

									
	Description	  	Room	  	Tag No.	  	Type	  	Cond
	 Collegeville Stack Guest Chair
	  	1423	  	2094	  	Seating	  	G
	 Eco 36 x 72 R/H Stepped Desk
	  	1423	  	2486	  	Desk	  	E
	 Eco 39 x 20 Desk Height L-Return
	  	1423	  	2487	  	L-Return	  	N
	 Eco 72 x 24 Kneespace Credenza
	  	1423	  	2489	  	Credenza	  	E
	 Framed Poster
	  	1423	  	546	  	Art	  	
	 Framed Poster: Mondrian
	  	1423	  	467	  	Art	  	
	 M2616 Display Telephone
	  	1423	  	1434	  	Phone	  	
	 Pompa HB Leather Desk Chair
	  	1423	  	2154	  	Seating	  	G
	 47 x 20 Desk Height U-Return
	  	1424	  	NT	  	U-Return	  	G
	 Collegeville Stack Guest Chair
	  	1424	  	2883	  	Seating	  	E
	 Framed Poster
	  	1424	  	2288	  	Art	  	
	 M2616 Telephone
	  	1424	  	NT	  	Phone	  	
	 Petri 36 x 72 L/H Stepped Desk
	  	1424	  	2885	  	Desk	  	G
	 Petri 98x19 Rear Unit
	  	1424	  	2515	  	Rear Unit	  	G
	 48 x 72 Wood/Wood Panel w/base
	  	1425	  	2666	  	Panel	  	E
	 EPH Desk Unit w/Peninsula & Overhead Shelf
	  	1425	  	644	  	Desk	  	G
	 EPH Desk Unit w/Peninsula & Overhead Shelf
	  	1425	  	2276	  	Desk	  	G
	 Framed Poster
	  	1425	  	791	  	Art	  	
	 Framed Poster: VanGogh Starlight Over Rh
	  	1425	  	150	  	Art	  	
	 Humanscale Liberty Task Chair w/arms
	  	1425	  	1635	  	Seating	  	N
	 Humanscale Liberty Task Chair w/arms
	  	1425	  	1636	  	Seating	  	N
	 Attache HB Leather Desk Chair
	  	1426	  	2544	  	Seating	  	G
	 Collegeville Stack Guest Chair
	  	1426	  	2558	  	Seating	  	E
	 Collegeville Stack Guest Chair
	  	1426	  	2872	  	Seating	  	E
	 Eco 36 x 72 Bookcase
	  	1426	  	2023	  	Bookcase	  	E
	 Eco 42 x 78 L/H Conference Desk
	  	1426	  	2299	  	Desk	  	G
	 Eco 54 x 25 Desk Height L/H BBF L-Return
	  	1426	  	2999	  	L-Return	  	G
	 Eco 66 x 19 Credenza
	  	1426	  	2300	  	Credenza	  	E
	 Framed Poster
	  	1426	  	861	  	Art	  	
	 M2616 II Display Telephone
	  	1426	  	936	  	Phone	  	
	 Eco 72 x 25 Desk Height FF (30”) L-Return
	  	1427	  	2996	  	L-Return	  	E
	 Eco 78 x 24 BBF Rear Unit
	  	1427	  	2201	  	Rear Unit	  	G
	 Eco 84” Overhead Unit
	  	1427	  	2296	  	Overhead Furniture	  	E
	 Framed Poster: Ecole de Botanique
	  	1427	  	1335	  	Art	  	
	 Meridian 30 x 20 5-Drawer Lateral File
	  	1427	  	673	  	File Cabinet	  	E
	 Meridian 30 x 20 Tall Storage Cabinet
	  	1427	  	2373	  	Storage Unit	  	E
	 48 x 25 Desk Height U-Return
	  	1428	  	2174	  	U-Return	  	G
	 Collegeville Stack Guest Chair
	  	1428	  	2367	  	Seating	  	E
	 Collegeville Stack Guest Chair
	  	1428	  	2368	  	Seating	  	E

  
  

							
	[] Symphony Suites. All Rights Reserved. CONFIDENTIAL Rev. 708	  	 	8	  	  	Initials: Client CF      Provider

									
	 Eco 36 x 72 Bookcase
	  	1428	  	2399	  	Bookcase	  	N
	 Eco 36 x 72 Bookcase
	  	1428	  	2674	  	Bookcase	  	E
	 Framed Poster
	  	1428	  	470	  	Art	  	
	 M2616 Telephone
	  	1428	  	NT	  	Phone	  	
	 Petri 42 x 84 L/H Stepped Arc Desk
	  	1428	  	2172	  	Desk	  	G
	 Pompa HB Leather Desk Chair
	  	1428	  	2213	  	Seating	  	G
	 48 x 20 Typing Height U Return
	  	1429	  	2601	  	U-Return	  	E
	 Collegeville Stack Guest Chair
	  	1429	  	2380	  	Seating	  	E
	 Framed Poster: Murnau Landscape
	  	1429	  	1318	  	Art	  	
	 M2616 Telephone
	  	1429	  	NT	  	Phone	  	
	 Petri 111 x 19 BBF/FF Rear Unit
	  	1429	  	2839	  	Rear Unit	  	E
	 Petri 36 x 78 L/H Stepped Desk
	  	1429	  	2798	  	Desk	  	E
	 Waveland LB Leather Desk Chair
	  	1429	  	2831	  	Seating	  	E
	 Contour II Leather Large Task Chair
	  	1430	  	723	  	Seating	  	G
	 Eco 36 x 20 Desk Height R/H L-Return (lam)
	  	1430	  	2694	  	L-Return	  	E
	 Eco 36 x 72 R/H Stepped Desk (lam)
	  	1430	  	2693	  	Desk	  	E
	 Eco 72 x 24 Credenza (lam)
	  	1430	  	2692	  	Credenza	  	E
	 Framed Poster
	  	1430	  	520	  	Art	  	
	 Framed Poster
	  	1430	  	548	  	Art	  	
	 48 x 20 Desk Height U Return
	  	1431	  	2177	  	U-Return	  	E
	 Attache HB Leather Desk Chair
	  	1431	  	2568	  	Seating	  	E
	 Collegeville Stack Guest Chair
	  	1431	  	2138	  	Seating	  	E
	 Collegeville Stack Guest Chair
	  	1431	  	2142	  	Seating	  	E
	 Eco 108 x 19 2 -Pedestal Rear Unit
	  	1431	  	2175	  	Rear Unit	  	E
	 Eco 108” Overhead Unit
	  	1431	  	2178	  	Overhead Furniture	  	E
	 Eco 36 x 84 L/H Conference U-Desk
	  	1431	  	2176	  	Desk	  	E
	 M2616 Telephone
	  	1431	  	1346	  	Phone	  	
	 Petri 36 x 72 Bookcase
	  	1431	  	2605	  	Bookcase	  	E
	 Attache LB Leather Conference Chair
	  	1432	  	2133	  	Seating	  	G
	 Attache LB Leather Desk Chair
	  	1432	  	19	  	Seating	  	G
	 Attache LB Leather Desk Chair
	  	1432	  	26	  	Seating	  	G
	 Attache LB Leather Desk Chair
	  	1432	  	2277	  	Seating	  	G
	 Framed Poster: Day to Day
	  	1432	  	1294	  	Art	  	
	 Quattro 48 x 84 Racetrack Table w/inlay & 6 mats
	  	1432	  	766	  	Table	  	G
	 Framed Poster: Port Costa
	  	1433	  	2165	  	Art	  	
	 Framed Poster: Wisteria
	  	1433	  	2164	  	Art	  	
	 Kimball 2 Drawer Cherry Lateral File
	  	1433	  	2203	  	File Cabinet	  	G
	 Kimball Cherry L/H L-Desk
	  	1433	  	604	  	Desk	  	G
	 M2616 Telephone
	  	1433	  	NT	  	Phone	  	
	 Meridian 30 x 20 5-Drawer Lateral File
	  	1433	  	2768	  	File Cabinet	  	E
	 Meridian 30 x 20 5-Drawer Lateral File
	  	1433	  	2769	  	File Cabinet	  	E
	 Meridian 30 x 20 Tall Storage Cabinet
	  	1433	  	2767	  	Storage Unit	  	E
	 Framed Poster: ‘Transition
	  	1434	  	2161	  	Art	  	
	 M2616 Telephone
	  	1434	  	1349	  	Phone	  	

  
  

							
	[] Symphony Suites. All Rights Reserved. CONFIDENTIAL Rev. 708	  	 	9	  	  	Initials: Client CF      Provider

									
	 Petri 36 x 72 Arc Front Double Ped Desk
	  	1434	  	2290	  	Desk	  	G
	 Petri 60” Computer Credenza w/Pedestal
	  	1434	  	2289	  	Credenza	  	G
	 Pompa HB Leather Desk Chair
	  	1434	  	2313	  	Seating	  	G
	 Post Medium Cherry Guest Chair (COM fabric)
	  	1434	  	2207	  	Seating	  	G
	 Eco 92 x 24 Rear Unit
	  	1435	  	2737	  	Rear Unit	  	G
	 Framed Poster
	  	1435	  	471	  	Art	  	
	 M2616 Telephone
	  	1435	  	1379	  	Phone	  	
	 Petri 36 x 72 Arc Front Ped Desk
	  	1435	  	2153	  	Desk	  	E
	 Pompa HB Leather Desk Chair
	  	1435	  	711	  	Seating	  	G
	 Post Medium Cherry Guest Chair (COM fabric)
	  	1435	  	2281	  	Seating	  	G
	 48 x 72 Wood/Wood Panel w/base
	  	1436	  	2686	  	Panel	  	E
	 Contour III LB Leather Task Chair T-arm
	  	1436	  	2687	  	Seating	  	E
	 Contour III LB Leather Task Chair T-arm
	  	1436	  	2701	  	Seating	  	E
	 Eco 36 x 25 Desk Height R/H L-Return
	  	1436	  	2704	  	L-Return	  	E
	 Eco 41 x 25 Desk Height L/H L-Return
	  	1436	  	2703	  	L-Return	  	E
	 Eco 77 x 30 BBF Rear Unit
	  	1436	  	2705	  	Rear Unit	  	E
	 Eco 77 x 30 BBF Rear Unit
	  	1436	  	2706	  	Rear Unit	  	E
	 Framed Artwork: Ocean Park #19
	  	1436	  	2162	  	Art	  	
	 Framed Artwork: Red Tiled Hillside
	  	1436	  	2160	  	Art	  	
	 Meridian 18” 5-Drawer Vertical File
	  	1436	  	2772	  	File Cabinet	  	E
	 Meridian 18” 5-Drawer Vertical File
	  	1436	  	2773	  	File Cabinet	  	E
	 Contour III LB Leather Task Chair T-arm
	  	1474	  	2075	  	Seating	  	E
	 EPH Desk Unit w/Peninsula & Overhead Shelf
	  	1474	  	646	  	Desk	  	G
	 Framed Poster: Matisse
	  	1474	  	468	  	Art	  	
	 M2616 Telephone
	  	1474	  	NT	  	Phone	  	
	 Meridian 36 x 20 5-Drawer Lateral File
	  	1474	  	2372	  	File Cabinet	  	E
	 Contour III LB Leather Task Chair T-arm
	  	1476	  	2668	  	Seating	  	G
	 Eco 30 x 24 2 Drawer Lateral File
	  	1476	  	3045	  	File Cabinet	  	E
	 Eco 30” Upper Bookcase
	  	1476	  	2600	  	Bookcase	  	E
	 Eco 48 x 31 Desk Height FF L-Return
	  	1476	  	2719	  	L-Return	  	E
	 Eco 77 x 24 BBF Rear Unit
	  	1476	  	2720	  	Rear Unit	  	E
	 Framed Poster: Chagall
	  	1476	  	469	  	Art	  	
	 M2616 Display Telephone
	  	1476	  	1412	  	Phone	  	
	 Tackboard 24 x 60
	  	1476	  	1582	  	Tackboard	  	N
	 Eco 30” Upper Bookcase
	  	1478	  	2581	  	Bookcase	  	E
	 Framed Poster
	  	1478	  	458	  	Art	  	
	 Framed Poster
	  	1478	  	460	  	Art	  	
	 Meridian 60 x 24 Rectangular Table
	  	1478	  	2287	  	Table	  	E

 Weekly Furniture Rental Charge $902 

  
  

							
	[] Symphony Suites. All Rights Reserved. CONFIDENTIAL Rev. 708	  	 	10	  	  	Initials: Client CF      Provider  

 Charges are billed monthly and the maximum charge in any full month will be based on four weeks billing.

 This Schedule may be amended to reflect requested changes in furnishings. However, if the Rate Basis is reduced for any furnishings, any
increased charges will be retroactive to the start of the rental period for the furnishings indicated. 
 Condition Codes 

N= New and unblemished. 
 E= Excellent-nearly new
with no visible surface scratches. 
 G= Good- Some surface wear may appear, but no surface scratches penetrate the polyurethane coating to the
wood. 
 F= Fair-Some minor scratches may appear on the work surface or edge only-side panels are free of all scratches. 

O= Other-see notes 

  
  

							
	[] Symphony Suites. All Rights Reserved. CONFIDENTIAL Rev. 708	  	 	11	  	  	Initials: Client CF      Provider   

 Add Office Amendment 
 Date: December 23, 2011 
 RE: Agreement No. 079-1436-11 

This Amendment to the referenced Agreement is prepared in accordance with Paragraph 20. 
 Whereas, You have requested to add services for an additional office(s) effective January 1, 2012 to the end of the referenced Agreement term, and We have agreed to same provided that: 

1) You are not in default of any of the terms of the referenced Agreement and, 

2) You have paid all charges billed prior to the above date and, 
 3) This Amendment is fully executed within 10 days from the above date and is returned with the additional security retainer shown in the attached Supplemental Schedule A prior to the effective occupancy
date above. 
 On the effective occupancy date above, the current Agreement and Monthly Contract Charges will be supplemented by the attached
SUPPLEMENTAL SCHEDULE A, and FURNITURE RENTAL SUPPLEMENT. 
 All other paragraphs, terms, and conditions of the referenced Agreement are
unmodified and remain in full force and effect. 
 The Parties hereto, on behalf of themselves, their heirs, executors, administrators and
assigns, have caused this Amendment to be duly executed as of the day and year first written above. 
  

					
	 Provider:
 Chartwell
Consulting Group, Inc.
 t/a Symphony Suites
 By
	 		 	 Client:
 Durata Therapeutics,
Inc.
  
 By

			
	

	 		 	

	Managing Officer	 		 	Title: COO
	Date: 1/21/12	 		 	Date: 1/3/12

  

 SUPPLEMENTAL SCHEDULE A 

FINANCIAL TERMS 
  

											
	 Quantity
	  	 MONTHLY CONTRACT CHARGES
	  	Unit
Charge	 	 	Total Monthly	 
	 1
	  	 Office Access** for Office/Suite No(s). 1422

Including office cleaning, maintenance services, heating and air conditioning during normal business
hours
	  	$	2,290	  	 	$	2,290	  
	 1
	  	Furniture Rental (see also Furniture Rental Supplement)	  	$	936	  	 	$	936	  
	 4
	  	Complete Multiline Telephone Equipment	  	$	95	* 	 	$	380	  
	 1
	  	Executive Telephone Upgrade w/display	  	$	40	  	 	$	40	  
		  	Dedicated Analog Modem Only Line	  	$	24	  	 			
		  	Dedicated Analog Fax & Modem Line	  	$	45	* 	 			
		  	Local Area Network Nodes (with IP address)	  	$	20	  	 			
	 4
	  	High Speed T-1 Internet Service (includes LAN node for each)	  	$	30	* 	 	$	120	  
		  	Additional Voice Mailbox + Message Center	  	$	45	  	 			
		  	Attendant Answering	  	$	50	  	 			
		  	Attendant Screening (1st person)	  	$	120	  	 			
		  	Attendant Screening (additional person)	  	$	60	  	 			
		  	Indoor Parking (where available)	  	$	65	  	 			
		  		  	$	0	  	 			
		  		  	$	0	  	 			
		  		  	$	0	  	 			
		  	Verizon Directory Listing	  	$	2	  	 			
		  	 TOTAL MONTHLY CONTRACT SERVICES/FACILITIES
	  				 	$	3,766	  
		  	 REFUNDABLE RETAINER
	  				 	$	7,532	  

  

	*	See current price schedule for one time setup charges 

 The above Services listing is not necessarily complete and may be amended from time to time to reflect changes in services and/or equipment. 

  

					
		  		  	Initials: Client CF      Provider  

 FURNITURE RENTAL SUPPLEMENT 
 Cadogan Resources, L.L.C. (referred to as “Cadogan” in this document) and Durata Therapeutics, Inc. (referred to as “You” 
 or “Your” in this document), make this additional Agreement (the “Supplement”) to the Office Services Agreement No. 079-1436-11 between You and Chartwell Consulting Group, Inc.
t/a SymphonySuites (referred to as “SymphonySuites” in this 
 document). 
 Cadogan agrees to rent to You and You agree to rent from Cadogan, on a week-to-week basis, the equipment and furniture listed on the Equipment/Furniture Addendum, on the reverse side of this page, for
the length of term indicated and under the terms and conditions set forth below. 

 

	1.	Your right to rent this equipment and furniture depends on Your Office Services Agreement with Symphony Suites, and if that Agreement ends, so will Your rights under
this Supplement. You may use this equipment and furniture only in connection with Your use of the designated office access, facilities and areas, provided to You by Symphony Suites, and only in accordance with the terms and provisions of the
Agreement with SymphonySuites. If You breach Your Agreement with SymphonySuites, Cadogan may, at its option, terminate this Supplement and Your rights in said equipment and furniture. Conversely, if You breach this Supplement, that breach will
also be a breach of Your Office Services Agreement with SymphonySuites. 

  

	2.	You agree to fully and timely pay in advance, the rental charges set forth on the Addendum, on the reverse side of this Supplement; and You also agree to fully and
timely satisfy the performances and requirements You have assumed in this Supplement with regard to said furniture and equipment. You agree to make all of Your payments to Cadogan, by making these payments to SymphonySuites – who serves as the
collection agent for Cadogan with regard to these payments. 

  

	3.	The equipment and furniture You are renting is, and shall always remain, the property of Cadogan. You are obligated to maintain said property in good physical
condition, and to protect Cadogan’s ownership rights in the furniture and equipment. Your obligations in this regard include the following: 

  

	 	a.	You must keep the equipment and furniture in good repair, condition and working order; 

 

	 	b.	You must not remove the equipment and furniture from the designated office area provided to You by SymphonySuites. 

 

	 	c.	You must use appropriate mats on all surfaces which are subject to direct contact or wear. You must return the equipment and furniture to Cadogan in good repair,
condition and working order. Conditions caused by ordinary wear and tear are acceptable, but not if this condition could have been prevented or lessened by Your using desk pads.

	 	d.	Only Cadogan is authorized to make repairs to the furniture. 

  

	 	e.	You will not use or offer Cadogan equipment or furniture as security for Your repayment of any debt or for the satisfaction of any of Your obligations.

  

	4.	You agree to protect and reimburse Cadogan from and with regard to all loss and/or damage Cadogan suffers because of Your failure to satisfy any of Your obligations
listed in this Supplement. Additionally, You are totally responsible for any and all loss or damage to the equipment and/or furniture regardless of how such loss or damage occurred. 

 

	5.	You agree to keep all rental equipment and furniture insured under an all risks/loss/damage insurance policy in an amount equal to what it would cost to fully replace
this equipment and furniture. You also agree to carry liability and property damage insurance covering this equipment and furniture and its use. The policies must be acceptable to Cadogan and SymphonySuites, and must defend, protect and reimburse
Cadogan and SymphonySuites against, and with regard to, all claims, liabilities, damages and costs connected with, and resulting from, this equipment and/or furniture and/or its use. 

 

	6.	You acknowledge that You are not permitted to transfer Your rights under this Supplement to anyone, and that any attempt by You, or anyone else, to transfer Your said
rights, will not be effective to actually cause such a transfer to occur. 

  

	7.	Neither SymphonySuites nor Cadogan make any guaranty expressly or implied to You or anyone else concerning the fitness of said equipment and furniture for any
purpose, its salability, design, condition, performance capabilities or any other aspect of said equipment and furniture or concerning its material or workmanship.

 

  
 We sign this Supplement below on
behalf of ourselves, everyone who succeeds to Our interests, and everyone to whom We may transfer Our rights under this Supplement with Cadogan’s consent. 
  

											
	Cadogan Resources L.L.C.	 		 		 	Durata Therapeutics, Inc.
						
	Signature	 	

	 	 as Agent
	 		 	Signature	 	

  

 EQUIPMENT/FURNITURE ADDENDUM 
 Rate Basis: 
  

									
	Tag	  	Description	  	Location	  	Type	  	Cond
	 1872
	  	M2616 II Display Telephone	  	1420	  	Phone	  	
	 2147
	  	Attache HB Leather Conference Chair	  	1420	  	Seating	  	E
	 2294
	  	Aspen Guest Chair (Streber Krauss)	  	1420	  	Seating	  	G
	 2336
	  	Eco 114 x 19 Top	  	1420	  	Rear Unit	  	E
	 2337
	  	Petri 19” L-Panel	  	1420	  	Rear Unit	  	E
	 2338
	  	Petri 36 x 19 FF Pedestal	  	1420	  	Rear Unit	  	E
	 2339
	  	Petri 16 x 19 BFF Pedestal	  	1420	  	Rear Unit	  	E
	 2340
	  	42 x 25 Desk Height U-Return	  	1420	  	U-Return	  	E
	 2341
	  	Petri 36 x 72 R/H Desk	  	1420	  	Desk	  	E
	 NT
	  	Framed Poster: Chagall	  	1420	  	Art	  	
	 787
	  	Framed Poster	  	1421	  	Art	  	
	 1696
	  	M2008 Telephone	  	1421	  	Phone	  	
	 1848
	  	M2008 Telephone	  	1421	  	Phone	  	
	 2682
	  	Eco 42 x 20 Desk Height L-Return	  	1421	  	L-Return	  	E
	 2683
	  	Eco 30 x 31 Desk Height L-Return	  	1421	  	L-Return	  	E
	 2684
	  	Eco 105 x 19 BBF Rear Unit	  	1421	  	Rear Unit	  	E
	 2685
	  	Eco 76 x 30 BBF Rear Unit	  	1421	  	Rear Unit	  	E
	 2688
	  	Contour III LB Leather Task Chair T-arm	  	1421	  	Seating	  	E
	 2701
	  	Contour III LB Leather Task Chair T-arm	  	1421	  	Seating	  	E
	 159
	  	Framed Poster: Stonington Inside Passage	  	1422	  	Art	  	
	 1194
	  	M2008 II Telephone	  	1422	  	Phone	  	
	 2074
	  	Contour III LB Leather Task Chair T-arm	  	1422	  	Seating	  	G
	 2333
	  	Eco 114 x 24 Top w/L-Panel	  	1422	  	Rear Unit	  	E
	 2334
	  	Eco 36 x 24 FF Pedestal	  	1422	  	Rear Unit	  	E
	 2334.1
	  	Eco 108x24 Top	  	1422	  	Rear Unit	  	E
	 2770
	  	Meridian 18” 5-Drawer Vertical File	  	1422	  	File Cabinet	  	E

 Weekly Furniture Rental Charge $234 

Charges are billed monthly and the maximum charge in any full month will be based on four weeks billing. 

This Schedule may be amended to reflect requested changes in furnishings. However, if the Rate Basis is reduced for any furnishings, any increased
charges will be retroactive to the start of the rental period for the furnishings indicated. 
 Condition Codes 

N= New and unblemished. 
 E= Excellent-nearly new
with no visible surface scratches. 
 G= Good- Some surface wear may appear, but no surface scratches penetrate the polyurethane coating to the
wood. 
 F= Fair-Some minor scratches may appear on the work surface or edge only-side panels are free of all scratches. 

O= Other-see notes 

  

					
		  		  	Initials: Client CF      ProviderRights Transfer Agreement

			
	 Confidential Materials omitted and filed separately with the

Securities and Exchange Commission. Asterisks denote omissions.
	 	Exhibit 10.9
		 	Execution Copy 12/14/2010

 RIGHTS TRANSFER AGREEMENT 
 This Rights Transfer Agreement (“Agreement”) is entered into as of December 14, 2010 (the “Effective Date”) by and between Durata Therapeutics, Inc., a Delaware
corporation (“Durata”), Vicuron Pharmaceuticals, Inc., a Delaware corporation (“Vicuron”), and RaQualia Pharma Inc., a Japanese Kabushiki Kaisha (“RaQualia”). Durata and RaQualia are referred to
herein together as the “Parties” and individually as a “Party”. 
 WHEREAS, Pfizer Inc., a
Delaware corporation (“Pfizer”), and RaQualia entered into a Dalbavancin Marketing Rights Agreement, dated as of June 30, 2008, as amended (the “Marketing Rights Agreement”), pursuant to which Pfizer granted
RaQualia certain rights to Commercialize the Product in Japan; 
 WHEREAS, Durata acquired from Pfizer and now owns all of the
outstanding shares of Vicuron; 
 WHEREAS, as part of the acquisition by Durata of Vicuron, Pfizer and Durata entered into an
Assignment Agreement, dated as of December 18, 2009 (the “Assignment Agreement”), pursuant to which Pfizer assigned its rights and obligations under the Marketing Rights Agreement to Durata; and WHEREAS, Durata and RaQualia are
willing to terminate the Marketing Rights Agreement in accordance with the terms set forth in this Agreement; 
 NOW, THEREFORE,
in consideration of the mutual covenants and promises contained in this Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Durata and RaQualia agree as follows: 

1. Definitions. For purposes of this Agreement, each of the following terms shall have the meaning set forth below: 

1.1 “Accounting Standard” means, with respect to a Person, generally accepted accounting principles as practiced in the
United States or applicable international standards followed by such Person. 
 1.2 “Affiliate” of a Person
means any other Person controlled by, controlling or under common control with such first-mentioned Person, where “control” means the direct or indirect ownership of fifty percent (50%) or more of the equity and voting rights
in such other Person. 
 1.3 “Business Day” means any day that is not a Saturday or a Sunday or a day on which
the New York Stock Exchange or the Tokyo Stock Exchange is closed. 
 1.4 “Calendar Quarter” means each of the
three (3) month periods ending on March 31, June 30, September 30, and December 31 of any year. 
 1.5 “Claim” means all charges, complaints, actions, suits, proceedings, hearings, investigations, claims and demands. 

  
 [Page 1 of 16]

 1.6 “Commercialization” or “Commercialize” means any and
all activities directed to obtaining marketing, pricing and reimbursement approvals, marketing, promoting, detailing, distributing, importing, exporting, offering for sale or selling a product. 

1.7 “Confidential Information” means any and all information disclosed by the Disclosing Party to the Receiving Party
that is confidential or proprietary or otherwise maintained as a trade secret, whether in oral, written, graphic or electronic form. Confidential Information shall not include any information that the Receiving Party can demonstrate by its written
or other tangible business records (a) is or becomes, through no act or failure to act on the part of the Receiving Party, generally known or generally available in the public domain; (b) is in the Receiving Party’s possession, free
of any obligation of confidence, at the time it is communicated to the Receiving Party by the Disclosing Party; (c) is rightfully communicated to the Receiving Party by a Third Party, free of any obligation of confidence; or (d) is
independently conceived by it without access to or use of such information. Information that is otherwise Confidential Information and consists of a combination of information shall not be deemed to be in the public domain if individual elements of
such information are in the public domain, unless the specific combination of those elements is also in the public domain. 

1.8 “Disclosing Party” means the Party disclosing Confidential Information (by itself or through its Affiliates) to the
other Party; provided, however, that Durata shall be considered the Disclosing Party with respect to (a) any information disclosed to RaQualia by Pfizer, and (b) any information with respect to the Product, regardless of the
source of the information; in each case, regardless of the exceptions in the definition of “Confidential Information”, except that the exceptions in clauses (a) and (c) shall apply solely if triggered after the Effective Date.

 1.9 “EMA” means the European Medicines Agency or any successor agency thereto. 

1.10 “Executive Officer” means, with respect to Durata and RaQualia, the chief executive officer of such Party (or
his/her executive level designee), respectively. 
 1.11 “External Delay Factor” means one or more of the
following events or circumstances with respect to the Product: (a) the effectiveness of any IND or protocol filed with a Regulatory Authority to conduct a clinical trial necessary or useful to obtain Regulatory Approval of the Product in Japan
is delayed; (b) any clinical study of the Product necessary or useful to obtain Regulatory Approval of the Product in Japan is suspended, put on hold, or terminated as a result of any action by any Regulatory Authority, institutional review
board (“IRB”) or independent data monitoring committee, or by or on behalf of Durata, its Affiliates or licensees based on IRB or independent data monitoring committee guidance; or (c) manufacturing or supply difficulties.

 1.12 “External Termination Factor” means one or more of the following events or circumstances with respect
to the Product: (a) failure to achieve the primary end points in a clinical study for the Product; (b) receipt of any materially adverse written communication from any Regulatory Authority regarding the approvability or approval of the
Product; (c) decisions by any Regulatory Authority not to approve the NDA for the Product or a material delay in such approval; or (d) material changes in applicable laws or regulations relating to the development, manufacture or
commercialization of the Product. 
  
 
 2
 

  
 [Page 2 of 16]

 1.13 “FDA” means the United States Food and Drug Administration or any
successor agency thereto. 
 1.14 “First Commercial Sale” means the first arms-length sale of the Product in
Japan to a Third Party distributer, agent or end user by or on behalf of Durata, its Affiliates or Licensees after Regulatory Approval has been obtained for the Product in Japan. 

1.15 “Governmental Authority” means any court, tribunal, arbitrator, agency, legislative body, commission, official or
other instrumentality of (a) any government of any recognized sovereign entity, (b) a federal, state, province, county, city or other political subdivision thereof, or (c) any supranational body. 

1.16 “IND” means an Investigational New Drug Application filed with FDA, or a similar application to conduct clinical
studies filed with an applicable Regulatory Authority outside of the United States. 
 1.17 “NDA” means a new
drug application or supplemental new drug application or any amendments thereto submitted to the FDA for marketing authorization of the Product in the United States, or any equivalent application in Japan. 

1.18 “Net Sales” means the gross amount invoiced by Durata, its Affiliate or Licensee on sales of the Product in the
Territory to a Third Party, less, to the extent included in such gross amount, actual deductions for: (i) trade, quantity and cash discounts and allowances to the extent actually allowed or taken; (ii) freight, other transportation,
warehousing, other storage, postage and insurance invoiced to such Third parties; (iii) amounts repaid or credited by reason of rejections or return of goods that are specifically identifiable as relating to the Product; (iv) customs
duties and sales, value-added, excise and other taxes related directly to the sale (excluding taxes assessed against the income derived from such sale); (v) allowances, adjustments, reimbursements, discounts, chargebacks and rebates related to
the sale of the Product that are granted to Third Parties, including rebates given to governmental entities and managed care organizations; and (vi) distributor commissions and fees payable to Third Party wholesalers for distribution of the
Product. To the extent that the sale of the Product occurs along with the sale of other products or services of Durata, its Affiliates or Licensees, all such discounts, allowances, credits, rebates and other deductions shall be fairly and equitably
allocated to the Product and other products or services of Durata, its Affiliates or Licensees such that the Products do not bear a disproportionate portion of such deductions. 

Such amounts shall be determined from the books and records of Durata, its Affiliates or Licensees, maintained in accordance with the
applicable Accounting Standards consistently applied by such Person. 
 Sales of a Product between or among Durata, its
Affiliates and Licensees for resale shall not be included in Net Sales, and Net Sales shall be calculated as above only on the first sale thereafter to a Third Party. 
 In the case of any sale of the Product for consideration other than cash, such as barter or countertrade, Net Sales shall be calculated on the fair market value of consideration received. 

 
 
 3
 

  
 [Page 3 of 16]

 Notwithstanding anything in this Agreement, the following dispositions shall not be included
in the calculation of Net Sales: disposition of (1) the Product for use in clinical trials required to seek or maintain Regulatory Approval of such Product in any country or in a Phase IV Clinical Study, and (2) a reasonable amount of
Product as samples following receipt of Regulatory Approval in Japan, or as part of a compassionate use, patient assistance, named patient or test marketing program or any similar program, in each case for which Durata, its Affiliates and Licensees
receive no revenue. 
 “Licensee” means a Third Party to whom Durata or Vicuron grants a license under any
patents owned by Durata or Vicuron to Commercialize the Product in Japan. 
 1.19 “Other Agreements” means any
letter of intent, memorandum of understanding or other agreement or arrangement of any kind (whether written or oral and whether or not binding), between or among Durata, Vicuron or Pfizer, on the one hand, and RaQualia, on the other hand, which
relates to the Product and exists on the Effective Date (other than this Agreement). 
 1.20 “Payment Period”
means the period beginning on the First Commercial Sale (if any) of the Product in Japan and ending on the tenth anniversary thereof or the last expiration of all patents owned by Durata or Vicuron as of the Effective Date which cover the sale of
the Product in Japan, whichever is later; where “expiration” means, with respect to an issued patent, that all claims in such patent have expired, been revoked or held unenforceable or invalid by a decision of a court or
governmental agency of competent jurisdiction from which no appeal can be taken, or with respect to which an appeal is not taken within the time allowed for appeal, or have been disclaimed or admitted to be invalid or unenforceable through reissue,
disclaimer or otherwise. 
 1.21 “Person” means an individual, corporation, partnership, limited liability
company, association, trust or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof. 
 1.22 “Phase IV Clinical Study” means a clinical study initiated after a Product has been granted Regulatory Approval in Japan, and which is aimed at strengthening the clinical evidence
for such Product to be used in the Commercialization of such Product. 
 1.23 “Pricing Approvals” means such
approval, agreement, determination or governmental decision establishing prices (i.e., Yakka) for the Product that can be charged to consumers and will be reimbursed by Governmental Authorities in Japan. 

1.24 “Product” means any pharmaceutical formulation, dosage or administration form of dalbavancin. 

1.25 “Product Item” means the Product, any active pharmaceutical ingredient (including dalbavancin or any salt, prodrug,
hydrate, solvate, metabolite, or polymorph form of dalbavancin) or excipients included in the Product, any drug substance for the Product, any drug product form of the Product, or any finished product or any intermediate forms of the Product.

  
 
 4
 

  
 [Page 4 of 16]

 1.26 “Receiving Party” means the Party, itself or through its Affiliates,
receiving Confidential Information from the other Party; provided, however, that RaQualia shall be considered the Receiving Party with respect to (a) any information disclosed to RaQualia by Pfizer, and (b) any information
with respect to the Product, regardless of the source of such information; in each case, regardless of the exceptions in the definition of “Confidential Information”, except that the exceptions in clauses (a) and (c) shall apply
solely if triggered after the Effective Date. 
 1.27 “Regulatory Approval” means any approval (including
supplements, amendments and Pricing Approvals), registration, license or authorization from any Governmental Authority required for the Commercialization of the Product in the relevant country, and shall include an approval, registration, license or
authorization granted in connection with any Regulatory Approval Application. 
 1.28 “Regulatory Approval
Application” means, with respect to a particular indication for a Product, the submission to the relevant Governmental Authority of an application seeking any Regulatory Approval, and shall include a marketing authorization application,
supplementary application or variation thereof, NDA or any equivalent application in Japan. 
 1.29 “Regulatory
Authority” means, in a particular country or jurisdiction, any applicable Governmental Authority involved in granting Regulatory Approval in such country or jurisdiction, including (a) in the U.S., the FDA and any other applicable
Governmental Authority in the U.S. having jurisdiction over the Product, and (b) the Ministry of Health, Labor and Welfare, otherwise referred to as “Kosei Rodo Sho” or any successor thereto, which govern the scientific review
of human pharmaceutical products in Japan. 
 1.30 “Safety Concern” means any toxicity, serious adverse event,
side effect or other safety finding, whether in vitro, in animals or in humans, that leads to a reasonable determination by Durata that the Product exposes or could expose animals or humans to an unacceptable safety risk in relation to therapeutic
benefit. 
 1.31 “Study Data” means all non-clinical, pre-clinical and clinical data and regulatory information
for the Product, whether in written or electronic form, with respect to research or development conducted by RaQualia or its designee, including broad data sets and study reports. 

1.32 “Terminated Agreements” means the Marketing Rights Agreement and any and all Other Agreements, if any. 

1.33 “Territory” means Japan. 
 1.34 “Third Party” means any Person other than the Parties and their respective Affiliates. 
 2. Termination. The Terminated Agreements are hereby terminated immediately and in their entirety (including those provisions stated to survive termination) as of the Effective Date, and the
Terminated Agreements shall have no further force or effect. All rights and obligations of the Parties, and/or any of their respective Affiliates, as applicable, under the Terminated Agreements shall cease and terminate immediately as of the
Effective Date. 
  
 
 5
 

  
 [Page 5 of 16]

 3. Upfront Payment. Durata will pay to RaQualia an aggregate, one-time sum of Three Hundred Fifty
Thousand United States Dollars (US$350,000) within [**] days of the Effective Date. RaQualia acknowledges that, except as provided in this Agreement, Durata is not liable to pay any amount to RaQualia (whether by way of compensation, damages,
reimbursement or otherwise) by reason of or in connection with the Terminated Agreements. 
 4. Commercialization Payments. 

4.1 Within [**] days after first receipt of the first Regulatory Approval for the Product in Japan (if any), Durata shall make a one-time
payment to RaQualia of Two Million United States Dollars (US$2,000,000). 
 4.2 During the Payment Period, Durata shall pay
RaQualia [**] percent ([**]%) of Net Sales for the Product in Japan during such period (the “Earned Income Payment”). Durata shall pay such amounts within [**] days after the end of each Calendar Quarter with respect to applicable
Net Sales in such Calendar Quarter. Each such payment will be accompanied by a royalty report, setting forth, in reasonable detail, the Net Sales and Durata’s calculation of the Earned Income Payment paid. Durata will provide an estimate of
Earned Income Payments for each Calendar Quarter during the Payment Period, based on information available to it, within [**] Business Days after the end of such Calendar Quarter. 
 5. Payment Provisions. 
 5.1 All amounts payable by Durata hereunder shall
be paid by electronic funds transfer to an account specified by RaQualia. Durata will pay the Earned Income Payment in Japanese Yen. 
 5.2 If any payments owed to RaQualia are paid after the date due, RaQualia shall be entitled to receive interest the aggregate amount of any payments that are not paid on or before the date such payments
are due under this Agreement at the rate of [**] percent ([**]%) per month (unless such rate is higher than the highest rate permitted by applicable law, in which case such rate will be changed to the highest rate permitted by applicable law),
calculated on the number of days such payments are paid after the date such payments are due. 
 5.3 Durata shall keep and
maintain records of its and its Affiliates’ Net Sales of the Product and the records it obtains from its Licensees with respect to their Net Sales of the Product. Such records shall be open to inspection upon [**] days prior notice and no more
than [**] each calendar year, at a time mutually convenient during normal business hours, by an independent public accountant, appointed by RaQualia for this purpose and reasonably acceptable to Durata, to have access, at RaQualia’s costs, to
such books of account of Durata to verify whether the amounts of the Earned Income Payment(s) are calculated or recorded properly in accordance with the Accounting Standards and this Agreement. Such independent public accountant shall enter into a
confidentiality agreement with Durata, pursuant to which it shall maintain such records as Durata’s confidential information and shall disclose to RaQualia only 

 
 
 6
 

  
 [Page 6 of 16]

 
the amounts (if any) by which the Earned Income Payments have been overpaid or underpaid. If such independent public accountant reasonably determines that such Earned Income Payment(s), after
adjustments in accordance with the Net Sales definition and Accounting Standard, have been understated by Durata, for any period, Durata shall pay the amount due for all Earned Income Payments not properly reported. If it is determined that Durata
has understated such Earned Income Payments by an amount equal to or greater than [**] percent ([**]%) in any audited period, Durata shall pay all reasonable fees and costs incurred by such independent public accountant in the course of making such
determination. The records required by this paragraph 5.3 shall be maintained and available for inspection for a period of [**] years following the Calendar Quarter to which they pertain. Any such records may be inspected no more than [**].

 5.4 Withholding Taxes. If any applicable laws or regulations require withholding of taxes on behalf of RaQualia from
any payment owed by Durata hereunder, such taxes will be deducted from such payment by Durata and will be remitted by Durata on behalf of RaQualia to the appropriate tax authority. Durata will furnish RaQualia with proof of payment of such taxes as
soon as practicable after such payment is made. 
 6. Reversion Right. 

6.1 Durata shall use reasonable efforts to file, or to have its Affiliate, licensee or designee file, a Regulatory Approval Application
for the Product in Japan within [**] months after the later of (a) the filing by Durata, its Affiliate, licensee or designee of a Regulatory Approval Application for the Product with the FDA and (b) the filing by Durata, its Affiliate,
licensee or designee of a Regulatory Approval Application for the Product with the EMA (the “Reversion Term”); provided, however, that (1) the obligations under this Sections 6.1 and Sections 4, 6.2, 6.3 and
6.4 shall terminate and Durata shall have no obligation to file or have filed a Regulatory Approval Application for the Product in Japan if, at any time, an External Termination Factor or Safety Concern arises, and (2) if, at any time, an
External Delay Factor arises, the period set forth in this Section 6.1 shall be automatically extended by the number of days between the date on which such External Delay Factor arises and the date on which such External Delay Factor has been
completely eliminated or resolved. For the avoidance of doubt, the Parties agree and acknowledge that Durata shall be under no obligation to seek or obtain Regulatory Approval for the Product in Japan. 

6.2 If Durata fails to fulfill its obligation pursuant to Section 6.1, then, as RaQualia’s sole remedy and Durata’s
exclusive liability, RaQualia may regain the rights to the Product in Japan on substantially the same terms as in the Marketing Rights Agreement and the Parties shall negotiate in good faith the terms of such an agreement (including any necessary
amendments to this Agreement), and, upon RaQualia’s written request to regain such rights, Durata’s obligations under Sections 4, 6.1, 6.3 and 6.4 shall automatically terminate. 

6.3 If, at any time, Durata notifies RaQualia in writing that Durata desires to terminate its obligations and RaQualia’s rights
under Sections 4, 6.1, 6.2 and 6.4, then, as RaQualia’s sole remedy and Durata’s exclusive liability, RaQualia may regain the rights to the Product in Japan on substantially the same terms as in the Marketing Rights Agreement and the
Parties shall negotiate in good faith the terms of such agreement (including any necessary 
  
 
 7
 

  
 [Page 7 of 16]

 
amendments to this Agreement), and, upon RaQualia’s receipt of Durata’s notice of such termination, RaQualia’s rights and Durata’s obligations pursuant to Sections 4, 6.1, 6.2
and 6.4 shall automatically terminate. 
 6.4 Once each calendar year, starting in 2011 and prior to the filing by Durata, its
Affiliate, licensee or designee of a Regulatory Approval Application for the Product in Japan, RaQualia shall have the right to require Durata to provide an annual report on the status of development of the Product for Commercialization in Japan,
including an estimated development schedule. 
 7. Representations and Warranties. 

7.1 Representations and Warranties of Durata and Vicuron. Durata and Vicuron represent and warrant to RaQualia that: 

(a) as of the Effective Date, Durata is a corporation duly organized and validly existing under the laws of the state or other
jurisdiction of incorporation or formation; 
 (b) Durata has all requisite power and authority to enter into this Agreement and
to perform its obligations under this Agreement; 
 (c) Durata’s execution, delivery and performance of this Agreement does
not and will not conflict with, violate or result in any breach of any relevant law or any provision of any agreement, contract, understanding, arrangement, commitment or undertaking of any nature (whether written or oral) to which Durata is a
party; 
 (d) no proceedings have been filed in any court, industrial commission or industrial or other tribunal by Durata or
its Affiliates against RaQualia prior to the Effective Date; 
 (e) Durata assumed, and is responsible for, all of Pfizer’s
obligations under the Marketing Rights Agreement pursuant to the Assignment Agreement; 
 (f) Durata owns all of the outstanding
shares of Vicuron; and 
 (g) Vicuron was the surviving entity in a merger between Vicuron and Versicor Inc., effective as of
March 26, 2003, which followed a merger of Biosearch Italia S.p.A and Versicor Inc., effective as of February 28, 2003, from which Versicor Inc. was the surviving entity; 

(h) as part of the acquisition by Durata of Vicuron, Pfizer and Durata entered into the Assignment Agreement, pursuant to which Pfizer
assigned its rights and obligations under the Marketing Rights Agreement to Durata; and 
 (i) Durata and Vicuron have no
information, as of the Effective Date, that would allow Durata or Vicuron to object to Pfizer having had the power to enter into the Marketing Rights Agreement on June 30, 2008 with respect to any patents owned by Vicuron as of such date with
respect to the Product. 
  
 
 8
 

  
 [Page 8 of 16]

 7.2 Representations and Warranties of RaQualia. RaQualia represents and warrants to
each of Durata and Vicuron that: 
 (a) as of the Effective Date, RaQualia is a corporation duly organized and validly existing
under the laws of the state or other jurisdiction of incorporation or formation; 
 (b) RaQualia has all requisite power and
authority to enter into this Agreement and to perform its obligations under this Agreement; 
 (c) RaQualia’s execution,
delivery and performance of this Agreement does not and will not conflict with, violate or result in any breach of any relevant law or any provision of any agreement, contract, understanding, arrangement, commitment or undertaking of any nature
(whether written or oral) to which RaQualia is a party; 
 (d) no proceedings have been filed in any court, industrial
commission or industrial or other tribunal by RaQualia or its Affiliates against Durata or Vicuron prior to the Effective Date; 

(e) other than this Agreement, the November 3, 2009 letter from Pfizer to RaQualia, and the assignment of the Marketing Rights
Agreement from Pfizer to Durata, there are no other amendments to the Dalbavancin Marketing Rights Agreement, dated as of June 30, 2008, by and between Pfizer, Durata or Vicuron, on the one hand, and RaQualia or its Affiliates, on the other
hand; 
 (f) as of the Effective Date, immediately prior to the execution of this Agreement, RaQualia and its Affiliates do not
own any assets related to any Product Item, nor have any other right, title or interest related to any Product Item, other than those contained in the Marketing Rights Agreement; 

(g) as of the Effective Date, immediately prior to the execution of this Agreement, neither RaQualia nor its Affiliates is a party to any
agreement relating to any Product Item, including any pharmacovigilance or quality agreement, other than the Marketing Rights Agreement; 
 (h) neither RaQualia nor its Affiliates has (i) assigned, sold, or otherwise transferred any legal rights relating to the Marketing Rights Agreement or any Product Item to any Affiliate or Third
Party, (ii) granted any Third Party any rights to Commercialize the Product in Japan, or (iii) granted any Third Party rights to, or requested any Third Party to, conduct any activities with respect to the Product, including any
non-clinical, clinical, regulatory, marketing, distribution or other activities; 
 (i) neither RaQualia nor its Affiliates has
undertaken or will undertake any activities to research, develop (including any non-clinical, pre-clinical or clinical development, whether in vitro or in vivo), manufacture or Commercialize any Product Item, other than entering into the Marketing
Rights Agreement and this Agreement; 
  
 
 9
 

  
 [Page 9 of 16]

 (j) neither RaQualia nor its Affiliates, nor, to RaQualia’s knowledge, any Third Party,
has registered, applied for registration or filed with any Governmental Authority the Manufacturing Rights Agreement or any other right or license with respect to any Product Item, including any trademark with respect to the Product; 

(k) as of the Effective Date, neither RaQualia nor its Affiliates, nor, to RaQualia’s knowledge, any Third Party, has published any
Confidential Information of Pfizer, Durata or Vicuron, whether or not such publication was approved in accordance with the Marketing Rights Agreement, or has otherwise disclosed any Confidential Information of Pfizer, Durata or Vicuron; 

(l) neither RaQualia nor its Affiliates, nor, to RaQualia’s knowledge, any Third Party, has provided nor will provide any
information to Pfizer pursuant to Section 3.5, Section 4.3, Section 4.4, Section 4.5, Section 4.6(b), Article 5 or Section 10.3 of the Marketing Rights Agreement; and

 (m) neither RaQualia nor its Affiliates, nor, to RaQualia’s knowledge, any Third Party, own or have in their possession
any inventory of any Product Item, any Study Data or any other assets relating to the Product, including any know-how (including information and data), contracts, materials, patent rights or trademarks. 

7.3 Disclaimer. THE WARRANTIES IN SECTION 7.1 AND SECTION 7.2 ARE IN LIEU OF ANY OTHER WARRANTY, WHETHER
EXPRESS OR IMPLIED, WRITTEN OR ORAL. 
 8. Non-Disclosure. 
 8.1 Each Party shall keep the existence and terms and conditions of this Agreement confidential and shall not now or hereafter disclose any part hereof to any Person except (a) with the prior written
consent of the other Party; (b) as otherwise may be required by law, regulation or legal process (including the law of any stock market or NASDAQ); (c) to its Affiliates, and its and its Affiliates’ employees and agents, who have a
need to know such information for purposes of exercising such Party’s rights or fulfilling such Party’s obligations under this Agreement and who are bound by confidentiality obligations no less protective of the other Party than the
provisions of this Section 8.1; (d) to legal counsel, accountants or other financial advisors representing such Party or its Affiliates and who are bound by conditions of confidentiality no less protective of the other Party than
the provisions of this Section 8.1; or (e) to its actual or bona fide potential directors, financing sources, acquirers, stockholders, licensors or licensees who are bound by confidentiality obligations no less protective of the
other Party than the provisions of this Section 8.1. Notwithstanding the above, no disclosure of this Agreement shall be made pursuant to clause (b) above without the Party subject to such disclosure obligation (i) first giving
the other Party reasonable prior notice of such intended disclosure (to the extent permitted by law) so as to allow such other Party sufficient time to seek a protective order or otherwise assure the confidentiality of this Agreement as such other
Party shall deem appropriate, (ii) taking all reasonable and lawful actions to obtain confidential treatment for such disclosure (including redacting financial terms wherever possible) and limiting the disclosure to the required purpose, and
(iii) at the other Party’s request and expense, assisting in an attempt to object to or limit the required disclosure. 
  

 10
 

  
 [Page 10 of
16] 

 8.2 Each Receiving Party shall (A) not use the Confidential Information of the
Disclosing Party for any purpose other than to exercise the Receiving Party’s rights or fulfilling the Receiving Party’s obligations under this Agreement, and (B) keep the Confidential Information of the Disclosing Party confidential
and not now or hereafter disclose any Confidential Information of the Disclosing Party to any Third Party except (a) with the prior written consent of the Disclosing Party; (b) as otherwise may be required by law, regulation or legal
process (including the law of any stock market or NASDAQ); (c) to its Affiliates, and its and its Affiliates’ employees and agents, who have a need to know such information for purposes of exercising such Party’s rights or fulfilling
such Party’s obligations under this Agreement and who are bound by confidentiality and non-use obligations no less protective of the other Party than the provisions of this Section 8.2; (d) to legal counsel, accountants or
other financial advisors representing such Party or its Affiliates who are bound by confidentiality and non-use obligations no less protective of the other Party than the provisions of this Section 8.2; or (e) to its actual or bona
fide potential directors, financing sources, acquirers, stockholders, licensors or licensees who are bound by confidentiality and non-use obligations no less protective of the other Party than the provisions of this Section 8.2.
Notwithstanding the above, no disclosure of Confidential Information of the other Party shall be made pursuant to clause (B)(b) above without the Party subject to such disclosure obligation (i) first giving the other Party reasonable prior
notice of such intended disclosure (to the extent permitted by law) so as to allow such other Party sufficient time to seek a protective order or otherwise assure the confidentiality of such other Party’s Confidential Information as such other
Party shall deem appropriate, (ii) taking all reasonable and lawful actions to obtain confidential treatment for such disclosure and limiting the disclosure to the required purpose, and (iii) at the other Party’s request and expense,
assisting in an attempt to object to or limit the required disclosure. 
 9. Indemnification. 

9.1 Indemnification by RaQualia. RaQualia shall defend, indemnify and hold harmless Durata, Vicuron and their respective
Affiliates, and their respective directors, officers, employees and agents, from and against any and all Claims, liabilities, damages, losses, costs and expenses (including the reasonable fees of attorneys and other professionals whose assistance is
reasonably required) to the extent arising out of or resulting from: 
 (a) any breach of any representation or warranty of
RaQualia contained in this Agreement; 
 (b) any failure to perform any covenant or agreement of RaQualia contained in this
Agreement; 
 9.2 Indemnification by Durata and Vicuron. Durata and Vicuron shall jointly and separately defend,
indemnify and hold harmless RaQualia and its Affiliates, and their respective directors, officers, employees and agents, from and against any and all Claims, liabilities, damages, losses, costs and expenses (including the reasonable fees of
attorneys and other professionals whose assistance is reasonably required) to the extent arising out of or resulting from: 

(a) any breach of any representation or warranty of Durata and/or Vicuron contained in this Agreement; 

 
 
 11
 

  
 [Page 11 of
16] 

 (b) any failure to perform any covenant or agreement of Durata and/or Vicuron contained in
this Agreement; and 
 (c) any liability relating to the Commercialization of the Product in Japan solely arising after the
Effective Date to the extent that such liability does not arise from any circumstance for which RaQualia is required to indemnify Durata or Vicuron pursuant to Section 9.1. 

9.3 Indemnification Procedure. In the event that any Person is seeking indemnification under this Section 9, such
Person (the “Indemnified Person”) shall (a) inform the Party required to provide indemnification hereunder (the “Indemnifying Party”) of the claim as soon as reasonably practicable after it receives notice of
the claim, (b) permit the Indemnifying Party to assume direction and control of the defense of the claim (including the right to settle such claim at its discretion, provided that no such settlement may be entered into without the
Indemnified Person’s consent if such settlement may adversely impact the Indemnified Person’s rights hereunder or otherwise assign liability to the Indemnified Person), and (c) cooperate as requested (at the expense of the
Indemnifying Party) in the defense of such claim. If both Parties are sued and it is reasonably likely that the Parties may have conflicting interests or if it is otherwise not advisable under applicable legal and ethical requirements for the
Indemnifying Party’s defense counsel to represent both the Indemnifying Party and the Indemnified Persons, separate independent counsel shall be retained for each, with the costs thereof borne by the Indemnifying Party (provided, that
the Indemnifying Party need not bear the costs of more than one law firm for all Indemnified Persons collectively). 
 10. Notices and
Language. 
 10.1 Notices. Any notice, request or other communication with respect to this Agreement shall be in
writing and shall be deemed to have been duly given if delivered personally, two (2) Business Days after being sent by reputable international overnight courier, or five (5) days after being sent by registered or certified mail, return
receipt requested, postage prepaid, in each case to the applicable Party at the respective addresses set forth below: 
 To Durata: 
 Durata Therapeutics, Inc. 

89 Headquarters Plaza North, Suite 306 

Morristown, NJ 07960 USA 
 Attention: Paul Edick, CEO 
  
 
 12
 

  
 [Page 12 of
16] 

 To Vicuron: 

Vicuron Pharmaceuticals, Inc 
 c/o Durata Therapeutics, Inc. 
 89 Headquarters Plaza North, Suite
306 
 Morristown, NJ 07960 USA 

Attention: Paul Edick, President 
 To RaQualia: 
 RaQualia Pharma Inc. 

5-2 Taketoyo, Aichi 470-2341, Japan 

Attention: Atsushi Nagahisa, President & CEO 

RaQualia shall send any notice to both Durata and Vicuron. 
 Either Party may change its address or the names or titles of the designated individual from that indicated by sending written notice not less than ten (10) days in advance of such change to the
other in the manner set forth above. 
 10.2 Language of Notices. Any communications under this Agreement shall be in
English. 
 11. Miscellaneous. 
 11.1 No Waiver. Any delay or omission by either Party to exercise any right or remedy under this Agreement shall not be construed to be a waiver of any such right or remedy or any right hereunder.
All of the rights of either Party under this Agreement shall be cumulative and may be exercised separately or concurrently. 

11.2 Applicable Law. This Agreement shall be governed by, performed under and construed in accordance with the substantive law of
the State of New York without giving effect to the conflict of laws principles thereof. 
  
 
 13
 

  
 [Page 13 of
16] 

 11.3 Dispute Resolution. 

(a) Initiation. Both Parties shall endeavor to settle amicably and promptly any disputes, controversies and differences which may
arise between the Parties out of or in relation to this Agreement or any breach thereof. In case such an amicable settlement is not attained within [**] Business Days after written notice of such dispute from any Party, either Party may invoke the
dispute resolution procedure set forth in Section 11.3(b) and (c) by giving written notice to the other Party. 

(b) Escalation. The Executive Officers shall, within [**] days after receipt of such notice, discuss, and attempt to resolve, the
dispute. Neither Party may commence arbitration of any matter hereunder until the expiration of such [**] day period. 
 (c)
Arbitration. Any dispute, controversy or claim arising out of or in connection with this Agreement, or breach, termination or invalidity thereof, that is not resolved by the procedure set forth in Section 11.3(b) shall be settled
by arbitration in accordance with the commercial arbitration rules of the International Chamber of Commerce (“ICC”). The arbitral tribunal shall be composed of three arbitrators, one to be appointed by Durata and one to be appointed
by RaQualia and the chairman to be appointed by the two arbitrators. If the two aforementioned Parties have not appointed their arbitrators within [**] weeks from the date on which arbitration was requested by either Party in writing, or the two
arbitrators have not agreed on the chairman within [**] weeks after their appointment, the ICC shall appoint the arbitrator or the chairman, as the case may be. In the event arbitration is requested by RaQualia, the place of arbitration shall be New
York; in the event arbitration is requested by Durata, the place of arbitration shall be Tokyo, Japan. The language to be used in the arbitral proceedings shall be English. The arbitrators shall be required to provide in writing to the Parties the
basis for the award or order of such arbitrators. 
 (d) Excepted Disputes. The obligations under Sections 11.3(a),
(b) and (c) shall not be binding upon any Party with respect to requests for preliminary injunctions, temporary restraining orders or other procedures in a court of competent jurisdiction to obtain interim relief when deemed necessary
by such court to preserve the status quo or to prevent irreparable injury pending resolution by arbitration of the actual dispute. 
 11.4 Assignment. No Party may assign, delegate or otherwise transfer any of its rights or obligations under this Agreement to any other Person without the prior written consent of the other Party,
except that (a) any Party may assign any right or obligation hereunder to its Affiliate; provided, that the assigning Party shall remain primarily liable for the obligations hereunder assigned to such Affiliate and send a written notice
to the other Party(ies) within [**] days after the assignment; and (b) any Party may assign this Agreement in its entirety to an acquirer of all or substantially all of its capital stock or its assets relating to this Agreement;
provided, that the assigning Party shall send a written notice to the other Part(ies) within [**] days after the assignment. Any purported or attempted assignment, delegation or other transfer of any rights or obligations under this Agreement
in contravention of the foregoing sentence shall be null and void. This Agreement shall inure to the benefit of and shall be binding upon the Parties and their successors, and, subject to this Section 11.4, permitted assigns. 

 
 
 14
 

  
 [Page 14 of
16] 

 11.5 Severability. In case any provision of this Agreement shall be invalid, illegal
or unenforceable, the validity, legality and enforceability of the remaining provisions of this Agreement will not in any way be affected or impaired thereby. 
 11.6 Interpretation. Section titles and headings contained in this Agreement are intended for convenience only and are not intended to effect the interpretation or construction of any term or
provision hereof. All references in this Agreement to a Section shall refer to a Section in this Agreement, unless otherwise stated. The words “herein,” “hereof” and “hereunder” and other words of similar import refer
to this Agreement as a whole and not to any particular section or other subdivision. The words “include,” “includes” and “including” when used in this Agreement shall be deemed in each case to be followed by the words
“without limitation.” 
 11.7 Counterparts. This Agreement may be executed in counterparts, each of which shall
be deemed to be an original, but all of which shall constitute one and the same instrument. Signatures provided by facsimile transmission or in AdobeTM Portable Document Format (PDF) sent by electronic mail shall be deemed to be original
signatures, but the Parties shall promptly exchange original signature pages to this Agreement. 
 11.8 Further
Assurances. Each Party shall (and shall ensure that its Affiliates shall) (a) furnish upon request to the other Party such further information, (b) execute and deliver to the other Party such other documents, and (c) do such other
acts and things, in each case as such other Party may reasonably request for the purpose of carrying out the purposes, terms and conditions of this Agreement. 
 11.9 Entire Agreement. This Agreement constitutes the entire agreement and understanding between the Parties as to the subject matter hereof and supersedes and replaces all prior or contemporaneous
agreements, understandings, negotiations, discussions and commitments, written or oral, as to such subject matter. Neither Party has relied upon any representation made by or on behalf of the other Party, other than as set out in this Agreement, in
entering into this Agreement. This Agreement is the result of negotiation between the Parties, each of which has been represented by counsel, and no provision shall be construed against for or against a Party due to the fact that a Party drafted any
portion of this Agreement. This Agreement may be changed only in a writing stating that it is an amendment or modification to this Agreement and signed by authorized representatives of each of the Parties. 

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK] 
  

 15
 

  
 [Page 15 of
16] 

 Execution Copy 12/14/2010 

IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the Effective Date. 

 

													
	RaQualia Pharma Inc.	 		 	Durata Therapeutics, Inc.
					
	By:	 	 /s/ Atushi Nagahisa
	 		 	By:	 	 /s/ Paul Edick

		 	Name:	 	 Atsushi Nagahisa
	 		 		 	Name:	 	 Paul Edick

		 	Title:	 	 President & CEO
	 		 		 	Title:	 	 Chief Executive Officer

  

					
	
	Vicuron Pharmaceuticals, Inc.
		
	 By:
	 	 /s/ Paul Edick

		 	 Name:
	 	 Paul Edick

		 	 Title:
	 	 President

 SIGNATURE PAGE TO RIGHTS
TRANSFER AGREEMENT 
  
 
 16
 

  
 [Page 16 of
16]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00201-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00201-of-00352.parquet"}]]